Company Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Equities

301520

CNE1000068J8

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Biotechnology & Medical Research

ANHUI WANBANG PHARMACEUTICAL TECHNOLOGY CO., LTD.

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
48.09 ^CNY	+0.12%		+4.89%	-13.04%

Apr. 19	Anhui Wanbang Pharmaceutical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Anhui Wanbang Pharmaceutical Technology Co., Ltd. has completed an IPO in the amount of CNY 1.131333 billion.	CI

Anhui Wanbang Pharmaceutical Technology Co Ltd is a China-based company primarily engaged in the provision of pharmaceutical research and clinical research services as a comprehensive contract research organization (CRO). The Company mainly provides professional pharmaceutical research and development outsourcing services to pharmaceutical companies and other pharmaceutical research and development institutions. The Company's services mainly include pharmaceutical research services such as generic drug development and consistency evaluation services, as well as clinical research services such as clinical trial operations, clinical trial site management, biological sample analysis, data management and statistical analysis. The Company mainly operates its businesses in the domestic market.

Number of employees: 160

CNY in Million	2022	Weight	2023	Weight	Delta
Clinical Research Services 71.3 %	188	72.1 %	244	71.3 %	+29.54%
Pharmaceutical Research Services 17.7 %	50	19.2 %	60	17.7 %	+20.86%
Other 11.0 %	8	3.1 %	38	11.0 %	+366.58%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	261	100.0 %	342	100.0 %	+31.07%

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	66,666,667	16,500,171 ( 24.75 %)	0	24.75 %

Name	Equities	%	Valuation
China Merchants Fund Management Co., Ltd. 0.001012 %	160	0.001012 %	1 107 ¥

Name	Equities	%	Valuation
Chun Lei Tao 51.96 %	26,427,800	51.96 %	183 M ¥
Xin Luo Xu 19.12 %	9,726,200	19.12 %	67 M ¥
Hefei Bairibang Equity Investment Partnership LP 9.164 %	4,661,000	9.164 %	32 M ¥
Ye Yin Qian 3.666 %	1,864,400	3.666 %	13 M ¥
Jiangsu Tianhui Sumintou Industrial Investment Co. Ltd. 3.072 %	1,562,500	3.072 %	11 M ¥
Zibo Zhaofeng Venture Capital Partnership LP 3.055 %	1,553,650	3.055 %	11 M ¥
Ying Shen 2.749 %	1,398,300	2.749 %	10 M ¥
Wenlong Sima 1.833 %	932,200	1.833 %	6 M ¥
HANGZHOU TIGERMED CONSULTING CO., LTD 1.527 %	776,850	1.527 %	5 M ¥
Hefei Hangbang Enterprise Management Partnership LP 1.335 %	678,950	1.335 %	5 M ¥

Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Anhui Wanbang Pharm Bldg 1 Mingzhu Avenue corner Huolongdi Road

230000, Hefei

http://www.ahwbyy.cn

address Anhui Wanbang Pharmaceutical Technology Co., Ltd.(301520)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
ANHUI WANBANG PHARMACEUTICAL TECHNOLOGY CO., LTD.	-13.04%	444M
MODERNA, INC.	+22.56%	46.71B
IQVIA HOLDINGS INC.	-1.51%	41.52B
LONZA GROUP AG	+48.83%	41.8B
CELLTRION, INC.	-3.42%	29.55B
ICON PUBLIC LIMITED COMPANY	+10.13%	25.78B
ALNYLAM PHARMACEUTICALS, INC.	-20.44%	19.26B
MEDPACE HOLDINGS, INC.	+26.45%	11.98B
BIO-TECHNE CORPORATION	-0.14%	12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.47%	12.08B

Other Biotechnology & Medical Research